Zobrazeno 1 - 10
of 187
pro vyhledávání: '"Finn, Waagstein"'
Autor:
Jose Lopez-Sendon, Karl Swedberg, John McMurray, Juan Tamargo, Aldo P. Maggioni, Henry Dargie, Michal Tendera, Finn Waagstein, Jan Kjekshus, Philippe Lechat, Christian Torp-Pedersen
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 1, Iss 1, Pp 49-69 (2015)
Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease.
Externí odkaz:
https://doaj.org/article/e059155ccecd423f87c140c6150c4307
Autor:
Ravi Masson, Bertram Pitt, Wen-Chih Wu, Richard M. Allman, Finn Waagstein, Milton Packer, Awais Malik, Steven N. Singh, Gregg C. Fonarow, Ali Ahmed, Charity J. Morgan
Publikováno v:
Journal of the American College of Cardiology. 74:617-627
Background The deleterious effects of discontinuation of digoxin on outcomes in ambulatory patients with chronic heart failure (HF) with reduced ejection fraction (HFrEF) receiving angiotensin-converting enzyme inhibitors are well-documented. Objecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a03f0880557684b6f52d55834caf8059
https://doi.org/10.1016/j.jacc.2019.05.064
https://doi.org/10.1016/j.jacc.2019.05.064
Autor:
G. Gelbrich, Stephan von Haehling, Biljana Putnikovic, Natasa Cvetinovic, Hans-Dirk Düngen, Goran Loncar, Svetlana Apostolović, Nikola Sekularac, Mitja Lainscak, Finn Waagstein, Simona Inkrot, Elvis Tahirovic, Andja Aleksic
Publikováno v:
Biomarkers in Medicine. 12:1261-1270
Aim: We investigated if the baseline value of mid-regional pro-atrial natriuretic peptide (NP), N-terminal pro-B-type NP and copeptin may be helpful in optimizing β-blocker uptitration in elderly patients with heart failure. Patients & methods: Acco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccb73fa2dd9bb6e721ef2b1de38879ec
https://doi.org/10.2217/bmm-2018-0136
https://doi.org/10.2217/bmm-2018-0136
Autor:
Cherinne Arundel, Wilbert S. Aronow, Helen Sheriff, Ali Ahmed, Gregg C. Fonarow, Richard M. Allman, Finn Waagstein, Poonam Bhyan, Phillip H. Lam, Charity J. Morgan, Daniel J. Dooley, Selma F. Mohammed
Publikováno v:
Clinical Cardiology. 41:406-412
BACKGROUND: Digoxin use has been associated with a lower risk of 30‐day all‐cause admission and readmission in patients with heart failure and reduced ejection fraction (HFrEF). HYPOTHESIS: Digoxin use will be associated with improved outcomes in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e82ed3871cb5be74702493c6fc30c495
https://doi.org/10.1002/clc.22889
https://doi.org/10.1002/clc.22889
Autor:
John D. Rutherford, Finn Waagstein
Publikováno v:
Circulation. 136:889-893
Finn Waagstein was born in Copenhagen in 1938. He graduated from Aarhus University Medical School in 1964. He received his cardiology training in the Sahlgrenska University Hospital at the University of Gothenburg, Sweden. He was appointed Associate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e6b62cfe6c728446d796ccad292030b
https://doi.org/10.1161/circulationaha.117.029934
https://doi.org/10.1161/circulationaha.117.029934
Autor:
Olaf Sowade, Felicitas Escher, Heinz-Peter Schultheiss, Harald Siedentop, Georg Groetzbach, Cornelia Piper, Matthias Pauschinger, Uwe Kuehl, Finn Waagstein, Joachim Friedrich Kapp, Eloisa Arbustini, Karl Wegscheider
Publikováno v:
Clinical Research in Cardiology. 105:763-773
Chronic viral infections of the heart are considered one antecedent event leading to progressive dysfunction of the myocardium, often with an impaired prognosis due to a virus- or immune-mediated myocardial injury. Symptomatic treatment does not infl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e894b9b4a9486169dde555ee37628d0
https://doi.org/10.1007/s00392-016-0986-9
https://doi.org/10.1007/s00392-016-0986-9
Autor:
Finn Waagstein, Michel Komajda, Hans Wedel, John Kjekshus, John J.V. McMurray, John Wikstrand, Kevin Damman, John G.F. Cleland
Publikováno v:
European Journal of Heart Failure. 18:328-336
Aim We aimed to study the relationships of loop diuretic dose with renal function and clinical outcomes in patients with chronic heart failure (HF). Methods and results Loop diuretic dose at baseline was recorded in patients included in the Controlle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91c5fdaafa137377498c43719f9febdb
https://doi.org/10.1002/ejhf.462
https://doi.org/10.1002/ejhf.462
Autor:
Thomas E. Love, Richard M. Allman, Finn Waagstein, Wilbert S. Aronow, Charity J. Morgan, Prakash Deedwania, Kumar Sanam, Vikas Bhatia, Stefan D. Anker, Javed Butler, Navkaranbir S. Bajaj, Peter E. Carson, Ross D. Fletcher, Raya Kheirbek, Taimoor Hashim, Gregg C. Fonarow, Ali Ahmed, Sumanth D. Prabhu
Publikováno v:
The American Journal of Medicine. 128:715-721
BACKGROUND: Beta-blockers improve outcomes in patients with systolic heart failure. However, it is unknown whether their initial negative inotropic effect may increase 30-day all-cause readmission, a target outcome for Medicare cost reduction and fin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93c2c8095ffd6d3a2020a562ff820420
https://doi.org/10.1016/j.amjmed.2014.11.036
https://doi.org/10.1016/j.amjmed.2014.11.036
Autor:
Miloje Tomasevic, Finn Waagstein, Slavica Radovanovic, Hans-Dirk Düngen, Elvis Tahirovic, Milan Pavlović, G. Gelbrich, Sonja Šalinger-Martinović, Dragana Stanojević, Biljana Putnikovic, Mitja Lainscak, Lindy Musial-Bright, Ruzica Jankovic-Tomasevic, Danijela Djordjevic-Radojkovic, Svetlana Apostolović, Simone Inkrot
Publikováno v:
Cardiology Journal. 21:265-272
Background: The aim of our study was to examine regional differences in the demographics, etiology, risk factors, comorbidities and treatment of female patients with heart failure (HF) in the Cardiac Insufficiency BI soprolol Study in ELDerly (CIBIS-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85c67d7ea737edf15848501a3f0c87c1
https://doi.org/10.5603/cj.a2013.0117
https://doi.org/10.5603/cj.a2013.0117
Autor:
R. A. De Boer, Finn Waagstein, Jonathan Batty, Hazel L. White, John Kjekshus, John Wikstrand, Åke Hjalmarson, P. van der Harst, Alistair S. Hall, D. J. Van Veldhuisen, Anthony J. Balmforth
Publikováno v:
Clinical Pharmacology & Therapeutics, 95(3), 321-330. Nature Publishing Group
To explore the pharmacogenetic effects of the cytochrome P450 (CYP) 2D6 genotype in patients with systolic heart failure treated using controlled/extended-release (CR/XL) metoprolol, this study assessed the CYP2D6 locus for the nonfunctional * 4 alle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::038f2404a9affdda9a375921d754584a
Wiley Online Library
Wiley Online Library